Well have more rigorous evidence in a few years, and then you know, perhaps within the next five to 10 years, well actually have the capacity to say definitively yes, this drug is intervening on the biology of aging in a way that is going to give us a more healthy lifespan. Download the Straight Arrow app today to get the stories that matter free from manipulation, bias or agenda. Point phone camera here There are currently no FDA-approved longevity drugs, in part because the agency does not recognize aging as a disease
Abdullah S, Md S, Altamimi AA, Alahdal H, Ali R, Alkreathy HM, et al
References: [1]Zhang, Chenghong
Unlike tirzepatide (which also engages GIP receptors), semaglutide specifically targets GLP-1 receptors, delivering a powerful effect on metabolism
The article describes metformin as weight-neutral to slightly weight-reducing, on the order of 0 to 3 kg on average, while it places GLP-1 receptor agonists in the range of 5 to 15 kg over 6 to 12 months
This is the most dilute practical option and gives you six 5 mg doses from a single vial, though the larger liquid volume means the vial needs to be large enough to accommodate it
